Point-of-Care Testing Market - Industry Dynamics, Market Size, and Opportunity Forecast to 2033

Point-of-Care Testing Market: By product (Devices & Instruments, Testing Kits & Consumables); Test Type (Immunological PoC Tests, Nucleic Acid-Based PoC Tests, Biomarker-Based PoC Tests); Indication (Infectious Diseases (HIV, COVID-19, Others), Oncology (Cardiovascular Diseases, Metabolic Disorders, Respiratory Diseases, Neurological Disorders, Gastrointestinal Disorders, Others); Technology (Biosensor Technology, Microfluidic Lab-On-A-Chip Technology, Molecular Diagnostics, Immunoassays, Others); Sample Type (Blood, Urine, Saliva, Others); Mode of Purchase (Prescription-based Testing and Over the Counter (OTC) Testing); End Users (Hospitals & Clinics, Diagnostic Centers, Homecare Settings, Research Laboratories); Distribution Channel (Direct Distribution, Retail Pharmacies, Online Pharmacies)—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025–2033

Point-of-care testing market was valued at US$ 46.48 billion in 2024 and is projected to hit the market valuation of US$ 85.55 billion by 2033 at a CAGR of 7.33% during the forecast period 2025–2033. Read More

We Are Trusted By These Great Companies!

• Last Updated: 01-Jul-2025  |  Format:  |  Report ID: AA07251356